The first Turning Point Therapeutics trade was made in Q1 2020.
Since then Jim Simons bought shares four more times and sold shares on five occasions. The investor completely sold their stake between Q2 2022 and Q3 2022.
Avg closing price
Price range
Sold -7.4 Thousand shares
Q3 2022
Avg closing price
$75.07
Price range
$74.65
-
$76.01
Sold 60.4% shares (-11.3 Thousand shares)
Q2 2022
Avg closing price
$44.44
Price range
$24.32
-
$75.30
New holding (+18.7 Thousand shares)
Q1 2022
Avg closing price
$33.60
Price range
$24.73
-
$51.25
Sold -143 Thousand shares
Q3 2021
Avg closing price
$71.24
Price range
$61.00
-
$81.99
Increased shares by 20.6% (+24.4 Thousand shares)
Q2 2021
Avg closing price
$73.90
Price range
$62.93
-
$90.59
Increased shares by 246.9% (+84.2 Thousand shares)
Q1 2021
Avg closing price
$118.91
Price range
$88.19
-
$140.01
Sold 64.9% shares (-63 Thousand shares)
Q4 2020
Avg closing price
$109.56
Price range
$87.69
-
$130.94
Sold 35.8% shares (-54.1 Thousand shares)
Q3 2020
Avg closing price
$69.66
Price range
$56.99
-
$89.33
Increased shares by 55.2% (+53.8 Thousand shares)
Q2 2020